Allergy

Researchers compared the racial and ethnic representation of participants in food allergen trials with patients who experience food allergies.

“Pharmacies are processing prescriptions, our supply chain is fully operational, and most importantly, the first patients are now receiving neffy,” said Eric Karas, CCO of ARS Pharmaceuticals.

Ragweed season begins in late August and can run through early November.

The epinephrine nasal spray from ARS Pharmaceuticals has become the first and only needle-free epinephrine alternative and the first new delivery method for epinephrine in over 3 decades.

Recent research on food allergy highlights the mental health concerns of people living with a food allergy, how nutritional intervention can help children with food allergy, and that peanut introduction can reduce rates of new allergy in high-risk infants.

Test your knowledge of asthma and allergy triggers.

Dive in and learn more about the answers to yesterday’s quiz.

Test your knowledge of food allergies.

Researchers aimed to better understand the intricacies of local allergic rhinitis and how it differs from allergic rhinitis.

Dive in and learn more about the answers to yesterday’s quiz.

Test your knowledge of allergy and asthma clinical guidelines.

Check out this list of resources to share with patients who are managing an allergy or asthma diagnosis.

April showers might bring May flowers, but for some, the month also brings the return of allergy woes. This spring, breathe easy with these OTC allergy product recommendations.

Researchers presented their findings on hypersensitivity caused by antibiotics as well as the best ways pharmacists can test for it.

The average US household spent $645 on OTC products in 2022.

Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.

The approval was based on positive data from a phase 3 trial that showed patients treated with omalizumab were significantly more likely to tolerate peanut, milk, egg, or cashew protein without moderate to severe allergic symptoms.

An FDA-approval of Omalizumab would help reduce allergic reactions among 17 million people in the United States who have confirmed food allergies.

ADP101 is designed to treat allergy to 1 or more of the world’s most significant allergens including cashew, almond, chicken’s egg, cow’s milk, codfish, peanut, pecan, pistachio, salmon, sesame, soy, shrimp, walnut and wheat.

A study found that around 75% of children who had reported experiencing pollen-AR by the ages of 4 or 8 continued to have persisted in their condition until they reached 24 years of age.